Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.920
0.00 (0.00%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $151.02 million as of September 17, 2026. Its market cap has increased by 12.69% in one year.
Market Cap
151.02M
Enterprise Value
72.31M
1-Year Change
12.69%
Ranking
Category
Stock Price
$3.92
ChartMarket Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $151.02M, a decrease of -77.90%. That is a compound annual growth rate of -24.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 151.02M | -5.69% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -7.89% |
| Jun 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 167.85M |
| Outlook Therapeutics | 163.84M |
| Armata Pharmaceuticals | 163.60M |
| Canton Strategic Holdings | 162.95M |
| Spruce Biosciences | 158.54M |
| Jyong Biotech | 157.37M |
| Neumora Therapeutics | 156.20M |
| Codexis | 153.31M |